SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-11-001015
Filing Date
2011-08-29
Accepted
2011-08-29 11:42:04
Documents
10
Period of Report
2011-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 17575
2 AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED MAY 31, 2011 ex991.htm EX-99.1 1056368
3 MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED MAY 31, 2011 ex992.htm EX-99.2 387783
4 ANNUAL INFORMATION FORM ex993.htm EX-99.3 431482
5 CEO/CFO CERTIFICATIONS ex994.htm EX-99.4 42936
6 SIGNATURE kpmg.jpg GRAPHIC 4075
7 LOGO kpmglogo.jpg GRAPHIC 3170
8 LOGO kpmgsmall.jpg GRAPHIC 1677
9 PRODUCT PIPELINE productpipeline.jpg GRAPHIC 71150
10 LOGO logo.jpg GRAPHIC 11636
  Complete submission text file 0001279569-11-001015.txt   2064421
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 111061949
SIC: 2836 Biological Products, (No Diagnostic Substances)